Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs aspirin in acute non-cardioembolic ischemic stroke with cerebral microbleeds
ChiCTR2400093897Phase 3Not yet recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Noncardioembolic stroke (NCES) and cerebral microbleed (CMBs) comparing Cilostazol group with Aspirin group (2 arms). Primary endpoint: Stroke recurrence during follow-up period. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
cilostazolaspirin
03
Conditions
Noncardioembolic stroke (NCES)cerebral microbleed (CMBs)
Beyond the preview
Go deeper on ChiCTR2400093897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093897.